Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

IJTLD open

Showing results (261-270 of 296) with videos related to

Pageof 30
Sort By:
IJTLD Open|July 22, 2024
Severe outcomes among adults with TB during COVID-19T Jacobs, E Morden, M Smith, et al.
IJTLD Open|July 22, 2024
Update on <i>IJTLD OPEN</i>: the future is openH D Blackbourn, G B Migliori
IJTLD Open|July 5, 2024
A social enterprise model for TB detection and treatment through the private sector in PakistanS M A Zaidi, W Z Jamal, U Ibrahim, et al.
IJTLD Open|July 5, 2024
Chronic obstructive pulmonary disease related to wood smoke and impact of the combined exposure to tobaccoC A Torres-Duque, C Jaramillo, A Caballero, et al.
IJTLD Open|July 11, 2024
TB and poverty: the effect of rifampicin-resistant TB on household incomeA Ciobanu, V Plesca, S Doltu, et al.
IJTLD Open|August 12, 2024
Outcomes of people with TB reported to the WHO Global Clinical Platform of COVID-19M Bastard, D Falzon, S Bertagnolio, et al.
IJTLD Open|June 26, 2024
Timeliness metrics for screening and preventing TB in household contacts of pulmonary TB patients in KenyaD Nair, P Thekkur, I Mbithi, et al.
IJTLD Open|June 26, 2024
Screening of household contacts for TB infection in Cote d'IvoireR K N'Guessan, D A B Orsot, J M Ahui Brou, et al.
IJTLD Open|June 26, 2024
Commitment, partnerships and operational research: three priorities for 11 EMR countries to achieve TB eliminationM van den Boom, K Bennani, G B Migliori, et al.
IJTLD Open|January 19, 2026
Drug-resistant TB treatment outcomes and factors associated with discontinuation and LTFU in Germany: No1Lost study protocolM Gödecke, F Eberhardt, G Barten-Neiner, et al.
Pageof 30

Showing results (261-270 of 296) with videos related to

Sort By:
Pageof 30
IJTLD Open|July 22, 2024
Severe outcomes among adults with TB during COVID-19T Jacobs, E Morden, M Smith, et al.
IJTLD Open|July 22, 2024
Update on <i>IJTLD OPEN</i>: the future is openH D Blackbourn, G B Migliori
IJTLD Open|July 5, 2024
A social enterprise model for TB detection and treatment through the private sector in PakistanS M A Zaidi, W Z Jamal, U Ibrahim, et al.
IJTLD Open|July 5, 2024
Chronic obstructive pulmonary disease related to wood smoke and impact of the combined exposure to tobaccoC A Torres-Duque, C Jaramillo, A Caballero, et al.
IJTLD Open|July 11, 2024
TB and poverty: the effect of rifampicin-resistant TB on household incomeA Ciobanu, V Plesca, S Doltu, et al.
IJTLD Open|August 12, 2024
Outcomes of people with TB reported to the WHO Global Clinical Platform of COVID-19M Bastard, D Falzon, S Bertagnolio, et al.
IJTLD Open|June 26, 2024
Timeliness metrics for screening and preventing TB in household contacts of pulmonary TB patients in KenyaD Nair, P Thekkur, I Mbithi, et al.
IJTLD Open|June 26, 2024
Screening of household contacts for TB infection in Cote d'IvoireR K N'Guessan, D A B Orsot, J M Ahui Brou, et al.
IJTLD Open|June 26, 2024
Commitment, partnerships and operational research: three priorities for 11 EMR countries to achieve TB eliminationM van den Boom, K Bennani, G B Migliori, et al.
IJTLD Open|January 19, 2026
Drug-resistant TB treatment outcomes and factors associated with discontinuation and LTFU in Germany: No1Lost study protocolM Gödecke, F Eberhardt, G Barten-Neiner, et al.
Pageof 30